Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale See remarks sold 753 shares at $18.62 ($14,021)
  2. 4 Open-market sale President, R&D sold 2,252 shares at $18.62 ($41,932)
  3. 4 Open-market sale Chief Financial Officer sold 1,469 shares at $18.62 ($27,353)
  4. 4 Planned sale President and CEO sold 48,199 shares at $18.10 ($872,402)
  5. 4 Planned sale Chief Financial Officer sold 17,717 shares at an average $18.59 ($329,322)
  6. 4 Planned sale President, R&D sold 8,530 shares at $18.97 ($161,814)
  7. 4 Planned sale Chief Financial Officer sold 17,717 shares at $18.94 ($335,560)
  8. 4 Planned sale President and CEO sold 48,199 shares at $18.94 ($912,889)
  9. 4 Planned sale See remarks sold 4,508 shares at $20.03 ($90,295)
  10. 4 Open-market sale 10% owner sold 6,000,000 shares at $19.40 ($116,400,000)
  11. 4 Planned sale President and CEO sold 48,199 shares at $20.33 ($979,886)
  12. 4 Planned sale Chief Financial Officer sold 17,717 shares at $19.74 ($349,734)
  13. 4 Open-market sale Chief Financial Officer sold 1,459 shares at $18.61 ($27,152)
  14. 4 Open-market sale See remarks sold 748 shares at $18.61 ($13,920)
  15. 4 Open-market sale President, R&D sold 2,237 shares at $18.61 ($41,631)
  16. 4 Planned sale President, R&D sold 8,660 shares at $18.71 ($162,029)
  17. 4 Planned sale President and CEO sold 48,199 shares at $19.58 ($943,736)
  18. 4 Planned sale Chief Financial Officer sold 17,717 shares at $18.69 ($331,131)
  19. 4 Planned sale See remarks sold 50,000 shares at $19.09 ($954,500)
  20. 4 Planned sale Chief Financial Officer sold 187,163 shares at an average $16.97 ($3,176,865)

Page 1 of 16 · 320 filings